OLR1 and neoplasm: In prostate cancer cells, 15-LOX-1 overexpression and 13-HODE lead to PPAR gamma phosphorylation by MAPK signaling, which reduces PPAR gamma activities and increases cell proliferation and tumor growth [60,61,62].